• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Integrating incidence and prevalence of tardive dyskinesia.

作者信息

Kane J M, Woerner M, Borenstein M, Wegner J, Lieberman J

出版信息

Psychopharmacol Bull. 1986;22(1):254-8.

PMID:2873613
Abstract
摘要

相似文献

1
Integrating incidence and prevalence of tardive dyskinesia.迟发性运动障碍的发病率与患病率综合分析
Psychopharmacol Bull. 1986;22(1):254-8.
2
Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.成人使用非典型抗精神病药物时的迟发性运动障碍发生率：患病率和发病率。
J Clin Psychiatry. 2004;65 Suppl 9:16-20.
3
Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.与典型抗精神病药物相关的迟发性运动障碍发病率研究综述。
J Clin Psychiatry. 2000;61 Suppl 4:15-20.
4
Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
J Clin Psychiatry. 1981 Jan;42(1):16-22.
5
Incidence of tardive dyskinesia: five-year data from a prospective study.
Psychopharmacol Bull. 1984 Winter;20(1):39-40.
6
[Tardive dyskinesia. After more than 2 decades].
Encephale. 1989 Sep-Oct;15(5):471-85.
7
Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.根据原发性精神疾病诊断的迟发性运动障碍风险因素。
Hillside J Clin Psychiatry. 1987;9(1):3-11.
8
Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.迟发性运动障碍、轻度药物性运动障碍和药物性帕金森综合征：危险因素及地形分布
Acta Neurol Belg. 1999 Sep;99(3):176-81.
9
Tardive dyskinesia: epidemiologic factors as a guide for prevention and management.迟发性运动障碍：作为预防和管理指南的流行病学因素
Adv Biochem Psychopharmacol. 1985;40:15-24.
10
Persistent tardive dyskinesia in randomly assigned neuroleptic reduction, neuroleptic nonreduction, and no-neuroleptic history groups: preliminary results.随机分配的抗精神病药物减量组、抗精神病药物未减量组和无抗精神病药物使用史组中的持续性迟发性运动障碍：初步结果
Psychopharmacol Bull. 1984 Winter;20(1):27-32.

引用本文的文献

1
Comparative Study of Extrapyramidal Side Effects, Sexual Dysfunctions and Hyperprolactinaemia Using Typical and Atypical Antipsychotic Medications Among Patients with Schizophrenia in Maiduguri.迈杜古里精神分裂症患者中使用典型和非典型抗精神病药物的锥体外系副作用、性功能障碍和高催乳素血症的比较研究
Niger Med J. 2023 Dec 28;64(5):612-626. doi: 10.60787/NMJ-64-5-311. eCollection 2023 Sep-Oct.
2
Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications.迟发性运动障碍研究的历史发展、热点及趋势：对54年出版物的科学计量分析
Front Psychiatry. 2023 Jun 2;14:1194222. doi: 10.3389/fpsyt.2023.1194222. eCollection 2023.
3
Movement disorders of the mouth: a review of the common phenomenologies.
口腔运动障碍：常见现象学综述。
J Neurol. 2022 Nov;269(11):5812-5830. doi: 10.1007/s00415-022-11299-1. Epub 2022 Jul 29.
4
Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.用于治疗抗精神病药所致迟发性运动障碍的磷酸吡哆醛5-磷酸酯
Cochrane Database Syst Rev. 2015 Apr 13;2015(4):CD010501. doi: 10.1002/14651858.CD010501.pub2.
5
Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic.停用多巴胺受体阻断剂后迟发性综合征很少可逆：来自一家大学运动障碍诊所的经验。
Tremor Other Hyperkinet Mov (N Y). 2014 Oct 23;4:266. doi: 10.7916/D8MS3R8C. eCollection 2014.
6
Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.接受非典型抗精神病药物治疗患者的迟发性运动障碍：病例系列及病因与治疗考量简述
Drugs Context. 2014 Apr 9;3:212259. doi: 10.7573/dic.212259. eCollection 2014.
7
Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?迟发性运动障碍与CYP2D6基因变异的关联：活性代谢产物是否起作用？
J Psychopharmacol. 2014 Jul;28(7):665-70. doi: 10.1177/0269881114523861. Epub 2014 Mar 4.
8
Tardive dyskinesia: therapeutic options for an increasingly common disorder.迟发性运动障碍：针对一种日益常见疾病的治疗选择
Neurotherapeutics. 2014 Jan;11(1):166-76. doi: 10.1007/s13311-013-0222-5.
9
An update on tardive dyskinesia: from phenomenology to treatment.迟发性运动障碍的最新进展：从现象学到治疗
Tremor Other Hyperkinet Mov (N Y). 2013 Jul 12;3. doi: 10.7916/D88P5Z71. Print 2013.
10
Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.迟发性运动障碍药物基因组检测应用中的伦理与政策考量：以多巴胺D3受体为例
Curr Pharmacogenomics Person Med. 2011 Jun 1;9(2):94-101. doi: 10.2174/187569211795508448.